CytoDyn CYDY Cash Flow Statement (2009-2026)

OTC CYDY
$0.23 -0.01 (-4.17%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

CytoDyn Quarterly Cash Flow Statement

Periods 70 quarters
Latest Aug 2026

CytoDyn reported cash from operations of -$7.73M and free cash flow of -$7.73M for the quarter ended Aug 2026, down 215.3% year over year. This cash flow statement covers 70 quarters of results from May 2009 through Aug 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow May2009 Aug2009 Nov2009 Feb2010 May2010 Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025 Nov2025 Feb2026 May2026 Aug2026
Operating Activities
Net Income
-40.08M-41.29M-84.12M-20.99M-26.50M-13.70M-18.64M-11.57M-9.56M-11.92M-16.79M19.23M-4.77M-4.76M-5.96M-5.54M-22.61M-4.69M-9.86M-19.94M
Depreciation, Depletion & Amortization
Amortization of IntangiblesAmort. of Intangibles
Amortization of Deferred ChargesAmort. Deferred Charges
0.79M0.64M0.58M0.58M0.58M0.57M0.41M0.40M0.14M0.41M0.13M0.13M0.11M0.11M0.06M0.33M
Depreciation & Amortization (CF)Dep. & Amort.
0.25M0.13M0.12M0.10M0.05M0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.00M0.01M0.00M0.00M0.01M0.00M0.00M0.02M
Share-based CompensationStock Comp.
2.06M-0.44M2.02M1.34M1.78M0.44M0.72M0.50M0.57M0.87M0.47M0.14M0.54M0.34M0.60M0.18M0.18M0.45M0.82M0.52M
Deferred Taxes
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
-8.60M-0.16M0.01M0.00M-0.02M-0.96M0.74M-0.85M
Asset Writedowns and ImpairmentWritedown
1.59M5.56M64.58M2.70M17.93M
Other non-cash itemsOther Non-Cash
6.79M12.07M8.60M0.64M2.02M2.66M4.09M3.04M4.90M8.02M1.18M-0.08M-0.33M12.27M
Change in Working Capital
Change in ReceivablesChange Receivables
0.18M
Change in InventoryChange Inventory
-0.78M-0.33M-0.17M
Change in Accrued ExpensesChange Accrued Exp.
-6.74M5.84M8.64M-1.82M-0.21M-1.53M0.46M3.32M1.06M1.97M4.42M-14.30M1.05M0.93M0.99M0.92M17.58M-4.01M3.39M-3.93M
Change in Other Operating AssetsOther Assets Change
-1.72M2.61M0.86M1.60M-1.30M-0.93M-1.28M1.61M-1.32M-0.26M-0.92M1.78M0.45M1.25M1.36M-1.99M-0.19M-1.11M-0.72M0.59M
Change in Other Operating LiabilitiesOther Liabilities Change
1.17M1.91M2.25M2.25M2.25M2.75M3.00M
Other Working Capital ChangesOther WC Changes
1.72M-2.61M-0.86M-1.60M1.30M0.93M1.28M-1.61M1.32M0.26M0.92M-1.78M-0.45M-0.08M0.55M4.24M2.44M3.36M3.47M2.41M
Cash from OperationsCash from Ops.
-28.89M-11.05M-6.04M-11.07M-4.41M-6.22M-3.41M-4.50M-2.50M-2.34M-1.65M5.44M-3.59M-4.96M-5.66M-2.45M-4.35M-5.52M-4.93M-7.73M
Investing Activities
Capital ExpendituresCapex
0.01M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-0.01M-0.02M
Change in IntangiblesChange Intangibless
Other Investing Activities (as filed)Other investing (as filed)
5.80M0.51M6.54M0.04M0.04M0.09M
Cash from Investing ActivitiesCash from Investing
-0.01M-0.02M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
1.14M0.21M0.65M-0.71M
Long-Term Debt RepaymentsLT Debt Repayment
7.10M8.96M0.00M1.50M2.00M0.71M0.14M
Net Long-Term Debt Issued (Repaid)Net LT Debt
-7.10M-8.96M0.00M-1.50M-2.00M1.14M0.21M0.65M-1.42M-0.14M
Short-Term Debt repaymentsST Debt Repayment
Net Short-Term Debt Issued (Repaid)Net ST Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-7.10M-8.96M0.00M-1.50M-2.00M1.14M0.21M0.65M-1.42M-0.14M
Change in Capital Stock
Common Stock IssuedStock Issued
26.62M4.55M7.88M11.52M13.35M1.36M2.88M0.44M2.68M3.44M1.17M0.02M17.09M1.13M12.23M
Shares Repurchased
Net Shares Issued and RepurchasedNet Shares Issued
26.62M4.55M7.88M11.52M13.35M1.36M2.88M0.44M2.68M3.44M1.17M0.02M17.09M1.13M12.23M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
26.62M4.55M7.88M11.52M13.35M1.36M2.88M0.44M2.68M3.44M1.17M0.02M17.09M1.13M12.23M
Dividend Payments
Dividends Paid - PreferredDiv. Paid (Pref.)
0.41M0.15M0.65M0.38M0.37M0.36M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.36M0.38M0.37M
Dividends Paid - Common and PreferredDiv Paid (Total)
0.41M0.15M0.65M0.38M0.37M0.36M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.37M0.36M0.38M0.37M
Other financing activities (as filed)
4.62M0.68M-0.01M10.38M
Cash from Financing ActivitiesCash from Financing
31.23M4.55M7.88M11.52M2.33M14.73M1.35M4.02M0.65M3.63M3.44M9.67M0.02M1.17M-0.12M16.19M1.13M12.23M
Additional items
Change in Cash
2.33M-6.51M1.87M0.45M-2.07M8.51M-2.06M-0.48M-1.85M1.30M1.79M15.11M-3.59M-4.94M-4.50M-2.57M-4.35M10.67M-3.80M4.51M
Beginning Cash Balance
-887.79M-930.49M
Ending Cash Balance
8.88M2.36M4.23M4.68M2.60M11.11M9.05M8.57M6.72M8.02M9.81M24.92M21.34M16.40M11.90M9.33M4.98M15.66M11.85M16.36M
Free Cash FlowFCF
-28.90M-11.06M-6.04M-11.07M-4.41M-6.22M-3.41M-4.50M-2.50M-2.34M-1.65M5.44M-3.59M-4.96M-5.66M-2.45M-4.35M-5.52M-4.93M-7.73M
Net Cash FlowNCF
2.33M-6.51M1.84M0.45M-2.07M8.51M-2.06M-0.48M-1.85M1.30M1.79M15.11M-3.59M-4.94M-4.50M-2.57M-4.35M10.67M-3.80M4.51M
Interest Paid
0.02M0.01M0.02M0.01M0.01M0.00M0.05M-0.02M0.00M0.01M0.01M0.00M
Income Taxes PaidTaxes Paid

CytoDyn Cash Flow Statement API

Pull CytoDyn's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CYDY&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY